NasdaqCM - Nasdaq Real Time Price USD

Enveric Biosciences, Inc. (ENVB)

1.3221
-0.0379
(-2.79%)
As of 11:49:42 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Gross Profit
--
--
--
--
0
Operating Expense
9,342.4820
9,632.2660
18,296.6750
19,961.4440
27,069.7930
Operating Income
-9,342.4820
-9,632.2660
-18,296.6750
-19,961.4440
-27,069.7930
Net Non Operating Interest Income Expense
-0.4750
0.2190
3.7080
-5.2490
-10.3160
Other Income Expense
47.1180
65.9900
1,030.1480
9.3000
-29,351.5920
Pretax Income
-9,295.8390
-9,566.0570
-17,262.8190
-19,957.3930
-56,431.7010
Tax Provision
7.1990
8.9300
28.9130
-1,486.0600
-7,454.8050
Net Income Common Stockholders
-9,303.0380
-9,574.9870
-17,458.7610
-18,800.3230
-48,976.8960
Diluted NI Available to Com Stockholders
-9,303.0380
-9,574.9870
-17,458.7610
-18,800.3230
-48,976.8960
Basic EPS
-11.05
-19.04
-121.29
-195.00
-1.56k
Diluted EPS
-11.05
-19.04
-121.29
-195.00
-1.56k
Basic Average Shares
885.6520
502.8990
143.9370
96.4000
31.4890
Diluted Average Shares
885.6520
502.8990
143.9370
96.4000
31.4890
Total Operating Income as Reported
-9,342.4820
-9,632.2660
-16,448.4400
-27,415.1060
-64,623.4200
Rent Expense Supplemental
--
0
1,848.2350
0
1,125.2910
Total Expenses
9,342.4820
9,632.2660
18,296.6750
19,961.4440
27,069.7930
Net Income from Continuing & Discontinued Operation
-9,303.0380
-9,574.9870
-17,310.7730
-18,504.3470
-48,976.8960
Normalized Income
-9,339.3701
-9,611.3191
-18,124.5899
-18,512.9545
-23,529.0657
Interest Income
--
0.2190
3.7080
--
--
Interest Expense
10.2390
--
--
5.2490
10.3160
Net Interest Income
-0.4750
0.2190
3.7080
-5.2490
-10.3160
EBIT
-9,342.4820
-9,632.2660
-18,296.6750
-19,952.1440
-56,421.3850
EBITDA
-9,009.3780
-9,294.7770
-17,888.6450
-19,516.9430
-55,739.7730
Reconciled Depreciation
333.1040
337.4890
408.0300
435.2010
681.6120
Net Income from Continuing Operation Net Minority Interest
-9,303.0380
-9,574.9870
-17,310.7730
-18,504.3470
-48,976.8960
Total Unusual Items Excluding Goodwill
45.9900
45.9900
1,030.1480
9.3000
-29,351.5920
Total Unusual Items
45.9900
45.9900
1,030.1480
9.3000
-29,351.5920
Normalized EBITDA
-9,055.3680
-9,340.7670
-18,918.7930
-19,526.2430
-26,388.1810
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0001
0.0001
Tax Effect of Unusual Items
9.6579
9.6579
216.3311
0.6925
-3,903.7617
12/31/2021 - 5/4/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ABP Abpro Corporation
0.2701
-0.69%
 
XLO Xilio Therapeutics, Inc.
0.9099
+3.40%
 
EYEN Eyenovia, Inc.
1.6005
+41.64%
 
ARMP Armata Pharmaceuticals, Inc.
2.4389
+2.91%
 
PBM Psyence Biomedical Ltd.
5.46
-9.18%
 
KTTA Pasithea Therapeutics Corp.
1.0250
+8.82%
 
ENSC Ensysce Biosciences, Inc.
2.4300
-4.71%
 
KLTO Klotho Neurosciences, Inc.
0.2100
-9.09%
 
ONCO Onconetix, Inc.
0.0875
+7.73%
 
QNRX Quoin Pharmaceuticals, Ltd.
8.40
+5.13%